Hisense Medical grew 300% to 2017

Hisense Medical has quickly become a strong competitor in a 100 billion-level emerging industry from an intruder.

Hisense medical strategy signed in zhongdi medical

The day before, Hisense medical and medical Zhongdi signed a comprehensive strategic cooperation partner, the two sides will work together to promote China's mobile medical, remote medical treatment, hospital and other hospital information construction intelligence development

Qingda hospital, Hisense and Tencent jointly released the world's largest human digital liver database.

In November 11th, at the second China Digital Clinical Medical Application Technology Conference and the third digital medical academic conference in Shandong Province, the Tencent and the Zhejiang University were jointly undertaken by the Affiliated Hospital of Qiingdao University and the Zhejiang University. The open platform of digital liver database is officially released.

Hisense Medical Partners with Huiyi Kang Strategic Development Southwest Market

On October 26, 2017, Chengdu, Qingdao Hisense Medical Equipment Co., Ltd. and Sichuan Huiyi Kang Technology Co., Ltd. signed a strategic cooperation agreement, which marks a solid step for Hisense Medical's strategic development of the Southwest market. Both parties will fully cooperate in products, markets and projects to achieve a win-win situation and serve the hospital for the benefit of the public.

Qingda Affiliated Hospital: Hisense CAS Accurately Removes Large Abdominal Tumors in 4-year-old Girls

Ying Ying (a pseudonym), a 4-year-old cute little girl, is a foreign patient who attends the Pediatric Surgery Department of Qingda Affiliated Hospital. He only weighs 12 kg but has a huge stomach. After discovering a large retroperitoneal tumor, the local hospital recommended surgery at a higher level hospital. The child's parents took their children to a proper place for treatment. After arriving at the doctor's office of the Affiliated Hospital of Qingdao University, it was already a matter of two months after the discovery of the tumor. Now.